Navigation Links
Best care for the oldest lung cancer patients
Date:4/28/2010

Los Angeles, London, New Delhi, Singapore and Washington DC (April 29th, 2010) - Although more than two fifths of lung cancers are diagnosed in patients over 70, data from clinical trials on the safest and most effective treatments for this age group are scarce. Now Italian oncologists are conducting a number of trials targeting elderly patients with non-small cell lung cancer (NSCLC), and offer a review of the latest findings - and their recommendations - in the current issue of Therapeutic Advances in Medical Oncology, published by SAGE.

According to Paolo Maione, Antonio Rossi, Cesare Gridelli and colleagues from S.G. Moscati Hospital in Avellino, Italy, elderly patients have more co-morbidity and don't tend to tolerate toxic medical treatments as well as younger patients. This means that clinical findings from studies on younger populations don't necessarily apply to the majority of elderly patients with NSCLC.

More than half of all cases of advanced NSCLC are diagnosed in patients over 65, and recent Surveillance, Epidemiology and End Results (SEER) Program data from the United States show that patients aged 70 years or older account for 47 percent of all lung cancers. Most prospective clinical data on chemotherapy and molecularly targeted therapy for elderly NSCLC patients come from studies in advanced disease. Unfortunately, by the time most patients from any age group receive a lung cancer diagnosis, the majority already have metastatic disease and a systemic, palliative treatment is their primary therapeutic option.

Cisplatin-based chemotherapy is currently recommended as the standard approach for patients with advanced NSCLC. However, to date, no prospective phase III study has explored the reproducibility of this benefit in elderly patients, the authors say. "The evaluation of cisplatin-based chemotherapy in elderly patients, in our opinion should be a priority," says one of the study authors, Cesare Gridelli.


'/>"/>
Contact: Jayne Fairley
jayne.fairley@sagepub.co.uk
020-732-48719
SAGE Publications UK
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Oldest Epilepsy Drug Best for Children
2. Manhattans Oldest Dog Dies, Leaves Behind a Legacy of Teaching
3. Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day
4. Curcumin nanoparticles open up resistant cancers
5. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
6. Breakthrough in Predicting Invasive Breast Cancer
7. Comparison of available breast cancer risk assessment tools shows room for improvement
8. Breakthrough method predicts risk of invasive breast cancer
9. Researchers attack stem cells that cause colon cancer
10. ASTRO releases SBRT for lung cancer report
11. HPV Test Beats Pap Smear for Cancer Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Specialty Technical ... compliance and risk solutions , and Radar today ... management effectiveness gap-improvement program. , All organizations need ... on objectives. Organizations not only assess and treat ... to do this (risk managing) thereby embedding these ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Lynn Lester as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... honor Lynn Lester with this prestigious award,” said NAPW ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in safety, environment, health ... organization exclusively for professional women, boasting more than 700,000 ... pleased to present Lourinda with this important honor,” said ...
(Date:6/1/2015)... June 02, 2015 The National ... Tansey as a 2015-2016 inductee into its VIP ... this prestigious distinction for leadership in mental health. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor," said NAPW President Star Jones. ...
(Date:6/1/2015)... 2015 Carson Energy also announced they ... IRA transactions. AdvantaIRA Trust, LLC is the country’s largest ... to fund positions using IRA’s does 2 things:, 1. ... project, even if there current cash position will not ... source for Carson and their investors to be able ...
Breaking Medicine News(10 mins):Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2
... five elderly Americans living on their own takes a ... and illness. According to the report, more than 21% ... least one of these 33 potentially inappropriate medications in ... people should always avoid, including certain sedatives, long-acting drugs ...
... amounts of heart tissue is as safe for babies as ... radiofrequency catheter ablation (RFCA) treatment involves threading a catheter - ... of the heart which is struggling with an uncontrolled heartbeat, ... radiofrequency energy, similar to microwave heat, is used to destroy ...
... everything from heartburn to impotence have prompted one in eight ... retain critical information about the drug and possible side effects. ... Food and Drug Administration set up rules and made them ... have a considerable effect -- nearly a third of adults ...
... Group therapy can help breast cancer patients feel better, but ... therapy in addition to their medical treatment lived an average// ... therapy did not live any longer than the 77 who ... did report less pain and emotional distress -- especially if ...
... pump up their physiques should know that many over-the-counter ... Many people who buy these supplements are getting ripped ... that they purchased in stores. They analyzed the products ... listed on the label were actually contained in the ...
... and Drugs Department is beginning to bare its fangs ... offence under the Indian Drugs and Cosmetics Act, 1940. ... this common practice jeopardise the health of the masses ... drugs -- it also endangers the job prospects of ...
Cached Medicine News:
(Date:6/1/2015)... JOLLA, Calif. , June 1, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that Kleanthis G. Xanthopoulos , Ph.D. has ... as a member of Regulus, Board of Directors, ... biotechnology industry.  Paul Grint, M.D., who previously served ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
(Date:6/1/2015)... June 1, 2015 Select Medical Holdings Corporation ... Corporation, a joint venture that Select Medical Corporation ("Select") ... completed its previously announced acquisition of Concentra Inc.  Cressey ... venture. About Select Medical Corporation ... hospitals and outpatient rehabilitation clinics in the ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Alfacell Corporation,(Nasdaq: ACEL ) today announced ... at,the 5th Cancer Drug Research & Development conference ... ONCONASE stimulated,intracellular events as revealed by expression profiling ... show that ONCONASE conjugates,effectively kill human cancer cells ...
... the NYC Department of,Health "unveiled a brand new look for ... encourage New Yorker,s to ,get some.," The,Release said further that ... the campaign would include ads on TV and radio and,display ... 36 million,condoms were given out last year., Robert Peters, ...
Cached Medicine Technology:Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 2Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 3NYC Department of Health's 'Get Some NYC Condoms' Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters 2
... into the punctal opening to block tear ... long-term relief of dry eye symptoms, and ... its own natural tears:, Low-profile cap ... of cap design facilitates easy removal with ...
Extended Duration absorbable plugs are designed to provide patient comfort for up to 3 months. This long lasting plug is effective and economical for transient dry eye symptoms following surgery. Ext...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain™ Left-heart Lead Options to Fit Your Patient's Anatomy. Navigate moderately to greatly angled veins with high tortuosity....
Medicine Products: